Key facts
- Notable investors include Leaguer Financial, Suzhou Hengyue Venture Capital Management, Zhangjiagang Industrial Capital Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Jianlida
- ·The full record, as it builds
Funding rounds
No funding rounds for Jianlida are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jianlida
Manufacturer of industrial enzyme preparations designed to enhance efficiency and environmental sustainability in biochemical processes. The company offers highly efficient and environmentally friendly enzyme formulations, enabling food, pharmaceutical, and chemical industries to improve process performance and sustainable production.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Jianlida doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jianlida shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jianlida in its N-PORT filings yet. We sweep new filings monthly.